Akouos Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
53
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$449M
Akouos General Information
Description
Developer of genetic therapies intended for auditory function restoration and preservation. The company focuses on precision medicine targeting sensorineural hearing loss, research into gene-based interventions for high-acuity hearing, and a focus on unmet clinical needs in auditory health, enabling healthcare providers and patients affected by disabling hearing conditions to access investigational treatments with potential for long-term improvement in sensory connectivity and physiological hearing outcomes.
Contact Information
Website
www.akouos.com(Operating Subsidiary)
Corporate Office
- 645 Summer Street
- Suite 200
- Boston, MA 02210
- United States
Corporate Office
- 645 Summer Street
- Suite 200
- Boston, MA 02210
- United States
Akouos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Dec-2022 | $449M | Completed | Generating Revenue | ||
| 7. IPO | 26-Jun-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 03-Mar-2020 | Completed | Startup | |||
| 5. Early Stage VC (Series A) | 07-Aug-2018 | Completed | Startup | |||
| 4. Seed Round | 13-Nov-2017 | Completed | Startup | |||
| 3. Accelerator/Incubator | 05-Oct-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | 13-Oct-2016 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Akouos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed I | 2,058,855 | $0.000100 | $0.02 | $0.24 | $0.24 | 1x | $0.24 | 0.41% |
| Seed | 25,622,520 | $0.000100 | $0.02 | $0.28 | $0.28 | 1x | $0.28 | 5.06% |
Akouos Comparisons
Industry
Financing
Details
Akouos Competitors (12)
One of Akouos’s 12 competitors is Audion Therapeutics, a Venture Capital-Backed company based in Amsterdam, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Audion Therapeutics | Venture Capital-Backed | Amsterdam, Netherlands | ||||
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Spiral Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| Acousia Therapeutics | Venture Capital-Backed | Tubingen, Germany | ||||
| Sensorion | Formerly VC-backed | Montpellier, France |
Akouos Patents
Akouos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024397647-A1 | Compositions and methods for treating hearing loss in a human subject having a defective otoferlin gene | Pending | 11-Dec-2023 | ||
| EP-4823629-A1 | Compositions and methods for treating hearing loss in a human subject having a defective otoferlin gene | Pending | 11-Dec-2023 | ||
| WO-2025128559-A1 | Compositions and methods for treating hearing loss in a human subject having a defective otoferlin gene | Inactive | 11-Dec-2023 | ||
| AU-2023272166-A1 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Pending | 19-May-2022 | ||
| EP-4526452-A1 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Pending | 19-May-2022 | A61K48/005 |
Akouos Signals
Akouos Former Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Citadel Enterprise Americas | Hedge Fund | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Cowen Healthcare Investments | Venture Capital | Minority | ||
| EcoR1 Capital | Venture Capital | Minority |
Akouos ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Akouos FAQs
-
When was Akouos founded?
Akouos was founded in 2016.
-
Where is Akouos headquartered?
Akouos is headquartered in Boston, MA.
-
What is the size of Akouos?
Akouos has 53 total employees.
-
What industry is Akouos in?
Akouos’s primary industry is Drug Discovery.
-
Is Akouos a private or public company?
Akouos is a Private company.
-
What is the current valuation of Akouos?
The current valuation of Akouos is .
-
What is Akouos’s current revenue?
The current revenue for Akouos is .
-
How much funding has Akouos raised over time?
Akouos has raised $375M.
-
Who are Akouos’s investors?
5AM Ventures, Citadel Enterprise Americas, Cormorant Asset Management, Cowen Healthcare Investments, and EcoR1 Capital are 5 of 21 investors who have invested in Akouos.
-
Who are Akouos’s competitors?
Audion Therapeutics, Pacira BioSciences, Spiral Therapeutics, Acousia Therapeutics, and Sensorion are some of the 12 competitors of Akouos.
-
When was Akouos acquired?
Akouos was acquired on 01-Dec-2022.
-
Who acquired Akouos?
Akouos was acquired by Lilly USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process